Luprotas 22.5mg Injection

About Luprotas 22.5mg Injection

Luprotas 22.5mg Injection contains Leuprolide, a synthetic analogue of gonadotropin-releasing hormone (GnRH). It is frequently applied to ailments requiring hormone suppression.

Tell your doctor about all of your current medications and any past medical history of alcohol use, smoking, or osteoporosis before using Luprotas 22.5. Effective contraception is suggested during therapy, and it is not advised during pregnancy or breastfeeding.

Brand Name: Luprotas

Composition: Leuprolide

Mechanism of Action:

Leuprolide works by excessively boosting the body's natural synthesis of specific hormones (such as estrogen or testosterone), which first causes a spike and then results in a sharp decline in the amounts.

Uses:

         Prostate cancer

         Endometriosis

Dosage and Administration:

Typically, the 22.5 mg depot injection is given every three months (12 weeks) and is intended for long-acting release. A medical practitioner administers it by subcutaneous or intramuscular injection.

Side Effects:

         Hot flashes

         Sweating

         Decreased libido

         Erectile dysfunction (in men)

         Vaginal dryness (in women)

         Mood changes

         Bone pain

         Weight gain